Profile

Aaron K. Olson, MD

Aaron K. Olson, MD

Cardiology

On staff since July 2006

Academic Title: Assistant Professor, Division of Cardiology, Department of Pediatrics

Research Center: Center for Developmental Therapeutics

"I go to work each day striving to make new discoveries in the basic science mechanisms controlling cardiovascular disease in children. I hope to translate these discoveries into new therapies for pediatric patients. "

    • Choueiter NF, Olson AK, Shen DD, Portman MA
      Prospective open-label trial of etanercept as adjunctive therapy for kawasaki disease.
      20667551 The Journal of pediatrics , 2010 Dec. : 960-966.e1
    • Portman MA, Slee A, Olson AK, Cohen G, Karl T, Tong E, Hastings L, Patel H, Reinhartz O, Mott AR, Mainwaring R, Linam J, Danzi S
      Triiodothyronine Supplementation in Infants and Children Undergoing Cardiopulmonary Bypass (TRICC): a multicenter placebo-controlled randomized trial: age analysis.
      20837917 Circulation , 2010 Sept. 14 : S224-33
    • Portman MA, Slee A, Olson AK, Cohen G, Karl T, Tong E, Hastings L, Patel H, Reinhartz O, Mott AR, Mainwaring R, Linam J, Danzi S
      Triiodothyronine Supplementation in Infants and Children Undergoing Cardiopulmonary Bypass (TRICC): a multicenter placebo-controlled randomized trial: age analysis.
      20837917 Circulation , 2010 Sept. 14 : S224-33
    • Choueiter NF, Olson AK, Shen DD, Portman MA
      Prospective Open-Label Trial of Etanercept as Adjunctive Therapy for Kawasaki Disease.
      20667551 The Journal of pediatrics , 2010 July 26
    • Olson AK, Hyyti OM, Cohen GA, Ning XH, Sadilek M, Isern N, Portman MA
      Superior cardiac function via anaplerotic pyruvate in the immature swine heart after cardiopulmonary bypass and reperfusion.
      18849332 American journal of physiology. Heart and circulatory physiology , 2008 Dec. : H2315-20
    • Hyyti OM, Olson AK, Ge M, Ning XH, Buroker NE, Chung Y, Jue T, Portman MA
      Cardioselective dominant-negative thyroid hormone receptor (Delta337T) modulates myocardial metabolism and contractile efficiency.
      18523124 American journal of physiology. Endocrinology and metabolism , 2008 Aug. : E420-7
    • Olson AK, Protheroe KN, Scholz TD, Segar JL
      Activation of the mitogen-activated protein kinases and Akt in response to pulmonary artery banding in the fetal sheep heart is developmentally regulated.
      17878740 Neonatology , 2008 : 145-52
    • Olson AK, Protheroe KN, Segar JL, Scholz TD
      Mitogen-activated protein kinase activation and regulation in the pressure-loaded fetal ovine heart.
      16299265 American journal of physiology. Heart and circulatory physiology , 2006 Apr, : H1587-95
    • Olson AK, Protheroe KN, Scholz TD, Segar JL
      The mitogen-activated protein kinases and Akt are developmentally regulated in the chronically anemic fetal sheep heart.
      16638585 Journal of the Society for Gynecologic Investigation , 2006 Apr, : 157-65
  • Presentations Title Event Location Date
    Metabolic Substrate Utilization During C-Myc Induced Cardiac Hypertrophy July 1, 2009
  • Grant Title Grantor Amount Award Date
    The Marfan Trial- a Trial of Beta Blocker Therapy (Atenolol) vs. Angiotensin II Receptor Blocker Therapy (Losartan) in individuals with Marfan syndrome (MFS) National Institute of Health $unknown Feb. 1, 2008
    Role of Fcgamma Receptor Polymorphisms in Determining IVIG Response in Kawasaki Disease Thrasher Foundation Jan. 1, 2008

Overview

Board Certification(s)

Pediatrics
Pediatric Cardiology

Medical/Professional School

University of Minnesota , Minneapolis
University of Minnesota - Duluth School of Medicine, Duluth

Residency

Pediatrics, University of Chicago , Chicago

Fellowship

Pediatric Cardiology, University of Iowa Hospitals and Clinics, Iowa City
Pediatric Cardiology, University of Iowa Hospitals and Clinics, Iowa City

Clinical Interests

Neonatal heart disease

About My Work

http://www.seattlechildrens.org/research/developmental-therapeutics/labs-programs/olson-lab/

Research Focus Area

Cardiac Metabolism, Kawasaki Disease, Cardiac Hypertrophy, Genetic Cardiovascular Disease